Published in Can J Cardiol on December 01, 2013
Renoprotective effect of remote ischemic post-conditioning by intermittent balloon inflations in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol (2013) 3.49
Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: a prospective randomized study. Crit Care Med (2011) 3.12
Moderate procedural sedation and opioid analgesia during transradial coronary interventions to prevent spasm: a prospective randomized study. JACC Cardiovasc Interv (2013) 2.65
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv (2012) 2.54
Bivalirudin use and one-month outcome in the context of contemporary antiplatelet treatment: insights from the Greek Antiplatelet Registry. Cardiovasc Ther (2014) 1.98
Effect of Angiotensin converting enzyme inhibitors on soluble tumor-necrosis-factor-related apoptosis-inducing ligand levels - association with neointimal hyperplasia in drug eluting stents. J Interv Cardiol (2014) 1.98
Kounis syndrome: a manifestation of drug-eluting stent thrombosis associated with allergic reaction to contrast material. Int J Cardiol (2008) 1.86
Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens (2007) 1.70
Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study. Nephron Clin Pract (2006) 1.63
Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients. J Am Coll Cardiol (2013) 1.60
Preferred QT correction formula for the assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol (2010) 1.56
Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study. Nephron Clin Pract (2003) 1.45
Predicting torsade de pointes in acquired long QT syndrome: optimal identification of critical QT interval prolongation. Cardiology (2012) 1.45
The future of cardiovascular magnetic resonance in Greece: expectations and reality. Hellenic J Cardiol (2009) 1.39
Coronary stent implantation, eosinophils and the Kounis hypersensitivity associated acute coronary syndrome. Atherosclerosis (2011) 1.38
Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping. JACC Cardiovasc Interv (2011) 1.25
Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study. J Am Coll Cardiol (2012) 1.20
Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail (2010) 1.19
Frequency of inappropriate and nonrecommended prasugrel prescription: great variations. J Am Coll Cardiol (2014) 1.08
Adenosine plasma concentration increase by ticagrelor in patients with acute coronary syndrome: no cause for fear in clinical practice. J Am Coll Cardiol (2014) 1.07
Heart failure in beta-thalassemia syndromes: a decade of progress. Am J Med (2005) 1.06
Global vasomotor dysfunction and accelerated vascular aging in beta-thalassemia major. Atherosclerosis (2007) 1.00
Heart echinococcus cyst as an incidental finding: early detection might be life-saving. J Cardiothorac Surg (2010) 1.00
Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves. Int J Cardiol (2008) 0.95
Heart rate-dependence of QTc intervals assessed by different correction methods in patients with normal or prolonged repolarization. Pacing Clin Electrophysiol (2009) 0.93
Regional impairments of cortical folding in premature infants. Ann Neurol (2014) 0.93
Regional alterations in cerebral growth exist preoperatively in infants with congenital heart disease. J Thorac Cardiovasc Surg (2011) 0.91
Increased Prevalence and Severity of Coronary Artery Calcification in Patients with Chronic Kidney Disease Stage III and IV. Nephron Extra (2012) 0.91
Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med (2014) 0.91
Coronary artery spasm associated with eosinophilia: another manifestation of Kounis syndrome? Heart Lung Circ (2008) 0.90
Differential effect of ticagrelor versus prasugrel on coronary blood flow velocity in patients with non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: an exploratory study. Circ Cardiovasc Interv (2013) 0.89
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with diabetes. Diabetes Care (2013) 0.89
Acute left main coronary artery thrombosis due to cocaine use. J Cardiothorac Surg (2010) 0.87
Permanent and atrial-synchronized ventricular stimulation for clinically stable patients with normal or impaired left ventricular systolic function. Pacing Clin Electrophysiol (2007) 0.86
Stent restenosis, pathophysiology and treatment options: a 2010 update. Hellenic J Cardiol (2011) 0.85
Clopidogrel resistance: current aspects and future directions. Hellenic J Cardiol (2011) 0.85
AngioJet rheolytic thrombectomy versus local intrapulmonary thrombolysis in massive pulmonary embolism: a retrospective data analysis. J Endovasc Ther (2005) 0.85
Coronary stents, hypersensitivity reactions, and the Kounis syndrome. J Interv Cardiol (2007) 0.85
Coronary stent fracture: how frequent it is? Does it matter? Hellenic J Cardiol (2011) 0.85
Diagnostic role of plasma BNP levels in neonates with signs of congenital heart disease. Int J Cardiol (2009) 0.84
Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study. J Am Coll Cardiol (2015) 0.84
Premature atherosclerosis in non-transfusion-dependent β-thalassemia intermedia. Cardiology (2011) 0.84
Anesthetic drugs and Kounis syndrome. J Clin Anesth (2008) 0.83
Release of endothelin-1 from human endocardium after radiofrequency catheter ablation and coronary angioplasty: comparative results. Int J Cardiol (2005) 0.83
An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9. Int J Cardiol (2011) 0.83
Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI. J Am Coll Cardiol (2013) 0.83
Risk for transient ischemic attacks is mainly determined by intima-media thickness and carotid plaque echogenicity. Atherosclerosis (2006) 0.83
Cortical folding is altered before surgery in infants with congenital heart disease. J Pediatr (2013) 0.83
Usefulness of rate regulation through continuous ventricular pacing in patients with drug-controlled slower atrial fibrillation and normal or depressed left ventricular systolic function. Heart Vessels (2008) 0.83
Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies. Am Heart J (2009) 0.82
Long-term outcome of percutaneous coronary intervention: the significance of native coronary artery disease progression. Clin Cardiol (2011) 0.82
Autonomic effects of nebivolol versus atenolol in healthy subjects. Cardiovasc Drugs Ther (2004) 0.81
The heart seems to be the primary site and the target of anaphylaxis resulting in the development of Kounis syndrome. Intern Emerg Med (2012) 0.81
Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE). Int J Cardiol (2013) 0.81
Acute effect of sildenafil on central hemodynamics in mechanically ventilated patients with WHO group III pulmonary hypertension and right ventricular failure necessitating administration of dobutamine. Int J Cardiol (2012) 0.81
Kounis syndrome and simultaneous multivessel acute coronary syndromes after successful drug-eluting stent implantation. Int J Cardiol (2007) 0.81
First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients. Lipids Health Dis (2013) 0.81
Optimal QT/JT interval assessment in patients with complete bundle branch block. Ann Noninvasive Electrocardiol (2012) 0.81
Inflammation and chronic heart failure: from biomarkers to novel anti-inflammatory therapeutic strategies. Med Chem (2014) 0.81
Flat panel digital detector cinefluoroscopy late following SES or BMS implantation for detection of coronary stent fracture in asymptomatic patients. Int J Cardiol (2010) 0.80
Facilitating assessment of QT interval duration during ventricular pacing. Europace (2012) 0.80
Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemia. J Lipid Res (2010) 0.80
Predischarge QRS score and risk for heart failure after first ST-elevation myocardial infarction. J Card Fail (2008) 0.80
Revascularization strategies in multivessel and left main coronary artery disease: SYNTAX and beyond. Hellenic J Cardiol (2014) 0.80
Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study. Hellenic J Cardiol (2012) 0.80
Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting. Can J Cardiol (2011) 0.80